• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH110502W
Device Problems Material Separation (1562); Separation Failure (2547); Malposition of Device (2616); Detachment of Device or Device Component (2907); Activation Failure (3270)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2021
Event Type  malfunction  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2021, a patient was to be implanted with a 11mm x 5cm gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn device) to treat common iliac aneurysm.The patient's left common iliac aneurysm was ruptured and bleeding.Due to patient iliac artery anchoring area was too short, physician planned to place the anchoring area in the lower segment of abdominal aorta and to perform double iliac kissing technique.During the procedure, the guide wire was advanced to the lesion successfully.The 11mm x 5cm viabahn device and a 13mm x 10cm viabahn device were advanced through 12f long sheath at bilateral, with the proximal end at the same level in the abdominal aorta.Both deployment lines were pulled at the same time.The left 13mm x 10cm viabahn device expanded successfully.But the right 11mm x 5cm viabahn device was not enable to complete full expansion when it has been expanded about 80%.The physician pulled with higher force and completed the deployment, but device migrated.The deployment line cannot be pulled again and delivery system cannot be separated and removed.The delivery system and sheath were advanced forward, physician used a balloon to support dilatation but deployment line still cannot be pulled, device migrated again.Physician believed the deployment line was stuck at the end of device, therefore he cut the deployment line and removed delivery system, placed another 13mm x 5cm viabahn device at the proximal end.A 9mm x 8cm bare stent to placed at distal end to secure deployment line, avoiding deployment line drifting in the vessel.Patient tolerated the procedure.
 
Manufacturer Narrative
G3/g4: correction, combination product? - yes.A review of the manufacturing records indicated the lot met pre-release manufacturing specifications.Imaging evaluation: the image appears to demonstrate the proximal r viabhan is slightly distal to the vbh deployed in the left common iliac.The other images lack detail as to original deployment and can not be evaluated.Image depicts an inflated pta balloon.The images received cannot be used to perform a full imaging evaluation.The extent and accuracy of the observations and findings may be limited due to the completeness, format and/or quality of the available images provided for review.Gore cannot guarantee the images provided are accurate or lack alteration.Therefore, gore cannot guarantee all key findings have been captured or that the findings are accurate.
 
Manufacturer Narrative
The deliver catheter was discarded at hospital facility and was not made available for evaluation.The investigation, including evaluation of images, confirms the reported subsequent device migration, but could not confirm the cause for the reported partial deployment issue.Therefore, cause of the event cannot be established based on the available information.Further information regarding this event was requested by gore, but no further information has been reported, therefore this investigation is considered complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
qiong wang
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12335280
MDR Text Key267040892
Report Number2017233-2021-02281
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeCH
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/16/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/11/2023
Device Catalogue NumberVBH110502W
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/02/2021
Initial Date FDA Received08/18/2021
Supplement Dates Manufacturer Received08/02/2021
03/15/2022
Supplement Dates FDA Received11/26/2021
03/16/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/12/2020
Is the Device Single Use? Yes
Type of Device Usage A
Patient Sequence Number1
Treatment
12F LONG SHEATH, COOK12F LONG SHEATH, GOLD LABELED; 12F LONG SHEATH, COOK12F LONG SHEATH, GOLD LABELED
Patient Age67 YR
Patient SexMale
Patient Weight55 KG
-
-